share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  2024/06/08 10:22

Moomoo AI 已提取核心訊息

Cardio Diagnostics Holdings received a notice from Nasdaq on June 3, 2024, indicating non-compliance with the minimum bid price requirement, as its common stock has traded below $1.00 for 30 consecutive business days. The company has been granted a 180-day compliance period until December 2, 2024, to regain compliance.The company can regain compliance if its stock price closes at or above $1.00 for a minimum of ten consecutive business days before the deadline. If unsuccessful, Cardio Diagnostics may be eligible for an additional 180-day compliance period, provided it meets other Nasdaq Capital Market listing requirements and submits a written intention to cure the deficiency.The company is actively monitoring its stock price and considering all available options to regain compliance, including the possibility of a reverse stock split. The notice has no immediate effect on the listing or trading of the company's common stock and warrants on the Nasdaq Capital Market.
Cardio Diagnostics Holdings received a notice from Nasdaq on June 3, 2024, indicating non-compliance with the minimum bid price requirement, as its common stock has traded below $1.00 for 30 consecutive business days. The company has been granted a 180-day compliance period until December 2, 2024, to regain compliance.The company can regain compliance if its stock price closes at or above $1.00 for a minimum of ten consecutive business days before the deadline. If unsuccessful, Cardio Diagnostics may be eligible for an additional 180-day compliance period, provided it meets other Nasdaq Capital Market listing requirements and submits a written intention to cure the deficiency.The company is actively monitoring its stock price and considering all available options to regain compliance, including the possibility of a reverse stock split. The notice has no immediate effect on the listing or trading of the company's common stock and warrants on the Nasdaq Capital Market.
Cardio Diagnostics Holdings, Inc.於2024年6月3日收到納斯達克的通知,指出其股票價格連續30天低於1.00美元的最低買盤規則不符合要求。公司有時間至2024年12月2日,有可能會獲得爲期180天的延期,來達到納斯達克規定的要求。在此期間,如果該股票在至少連續業務10個交易日中收盤價爲1.00美元或更高,則符合要求。公司正在考慮期權來解決這個問題,包括進行股票拆分。然而,無法保證獲得符合要求或避免除牌。公司將繼續監控其股價並探索所有可用的業務解決缺陷。
Cardio Diagnostics Holdings, Inc.於2024年6月3日收到納斯達克的通知,指出其股票價格連續30天低於1.00美元的最低買盤規則不符合要求。公司有時間至2024年12月2日,有可能會獲得爲期180天的延期,來達到納斯達克規定的要求。在此期間,如果該股票在至少連續業務10個交易日中收盤價爲1.00美元或更高,則符合要求。公司正在考慮期權來解決這個問題,包括進行股票拆分。然而,無法保證獲得符合要求或避免除牌。公司將繼續監控其股價並探索所有可用的業務解決缺陷。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息